Latest News and Events
DTx Pharma Completes $10.6M Series A Financing
DTx Pharma announced today the final closing of a Series A financing totaling $10.6 million dollars. The round was led by San Diego-based FBV Fund 1 and included significant investment from Eli Lilly and Company (NYSE: LLY), Viva Biotech [...]
Partnership with DTx Pharma to optimize antisense oligonucleotides as a gene therapy for CMT1A
The CMT Research Foundation (CMTRF), a nonprofit focused solely on delivering treatments and cures for Charcot-Marie-Tooth, today announced it has partnered with DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide (short DNA or RNA molecules) drugs by overcoming [...]
DTx receives 3rd NIH SBIR in 2019: Targeting Tau in Neurodegenerative Disease
DTx received a notice of award in September for our first CNS focused grant, targeting the Tau gene/protein implicated in FTLD’s such as PSP as well as Alzheimer’s disease. This grant from the National Institute of Aging provides $225K in [...]
DTx Pharma to Attend Biotech Showcase at 2019 JP Morgan Healthcare Conference; Selected to Participate in West Coast Innovators Pitch Challenge
San Diego, CA. DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, today announced that it will attend the 2019 Biotech Showcase at the JP Morgan Healthcare Conference in San Francisco, CA from January 7-9, 2019. [...]
DTx Pharma was named by the San Diego Venture Group as one of their 30 Cool Companies of 2018
Diego, CA. DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, was named by the San Diego Venture Group (SDVG) as one of their 30 Cool Companies of 2018. According to their website, the SDVG [...]
DTx Pharma to Attend 2018 BIO International Convention
San Diego, CA. DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, today announced that it will attend the 2018 BIO International Partnering Convention in Boston, MA from June 4-7, 2018. “The single biggest obstacle limiting [...]